Study the Modern Techniques of Granulation in Pharmaceutical Solid Dosage Form

Abstract

Granulation is a critical process in the pharmaceutical industry, significantly influencing the manufacturing and quality of solid dosage forms such as tablets and capsules. Traditional granulation methods, including wet and dry granulation, have been widely employed for decades. However, modern pharmaceutical demands necessitate advanced granulation technologies that offer enhanced process control, scalability, product uniformity, and compliance with regulatory expectations such as Quality by Design (QbD) and Process Analytical Technology (PAT). This study explores the latest advancements in granulation techniques used for solid dosage forms, emphasizing their principles, applications, advantages, and challenges. Techniques such as high shear granulation, fluidized bed granulation, twin-screw granulation, melt granulation, spray drying, and moisture-activated dry granulation (MADG) are discussed in depth. The integration of PAT and continuous manufacturing systems into granulation processes is also evaluated to highlight how modern pharmaceutical manufacturing is evolving toward automation, real-time monitoring, and continuous improvement. Comparative evaluations provide insights into process efficiency, granule properties, scalability, and regulatory compliance. This thesis aims to provide a comprehensive understanding of modern granulation techniques and their pivotal role in advancing pharmaceutical manufacturing practices, enhancing product quality, and ensuring patient safety. The study concludes with an analysis of current challenges and the future scope of research in pharmaceutical granulation.

Introduction

Granulation is a key process in pharmaceutical manufacturing, transforming fine powders into granules to improve flowability, compressibility, and drug uniformity. Traditionally performed using wet and dry granulation, the growing complexity of drug formulations has driven the development of modern granulation techniques for better control, scalability, and quality compliance (e.g., QbD and PAT frameworks).

Types of Granulation Techniques:

1. Traditional Methods:

• Dry Granulation: Uses compaction without liquid or heat—suitable for moisture/heat-sensitive drugs.

• Wet Granulation: Involves binder addition followed by drying—enhances cohesion but is time-consuming.

• Variants:

  • Reverse Wet Granulation

  • Steam Granulation

  • Moisture-Activated Dry Granulation (MADG)

  • Melt Granulation

  • Pneumatic Dry Granulation

2. Modern Granulation Techniques:

• High-Shear Granulation: Fast, uniform granule production using mechanical mixing.

• Fluidized Bed Granulation: Combines granulation and drying in a single step.

• Twin-Screw Granulation (TSG): A continuous process ensuring high consistency and scalability.

• Hot-Melt Extrusion (HME): Ideal for poorly soluble drugs; avoids solvents.

• Foam Granulation: Uses foamed binders for uniform distribution and less binder usage.

• Spray Drying: Converts liquid feed to granules; good for heat-sensitive drugs.

• Supercritical Fluid Granulation: Solvent-free, advanced control, still under development.

• Microwave-Assisted Granulation: Energy-efficient, fast drying using microwave heat.

3. Role of PAT (Process Analytical Technology):

PAT ensures real-time monitoring and quality control of granulation parameters such as:

• Moisture content (NIR spectroscopy)

• Chemical uniformity (Raman spectroscopy)

• Granule size (FBRM)

• Binder activation (Dielectric Spectroscopy)

These tools enhance process understanding, enable automation, and reduce batch failures.

4. Comparative Evaluation:

• Wet Granulation: High granule quality but energy-intensive.

• Dry Granulation: Simple but produces weaker granules.

• Modern Methods: Offer better control, continuous processing, and suitability for complex formulations.

  • TSG and HME particularly support real-time monitoring and consistent output.

5. Applications:

• Tablet Uniformity: Enhanced blend homogeneity.

• Controlled Release: Enabled by HME and spray drying.

• Bioavailability: Improved for poorly soluble drugs.

• Continuous Manufacturing: Reduces variability, cost, and production time.

6. Challenges & Future Scope:

• High Equipment Costs: Barrier for small-scale companies.

• Process Scale-Up: Difficult due to complex variables.

• Regulatory Hurdles: Need for detailed validation and documentation.

• Raw Material Sensitivity: Can affect granule quality.

• Energy Usage: Especially with fluidized bed and spray drying methods.

Conclusion

The advancement of modern granulation techniques marks a transformative phase in pharmaceutical solid dosage form development. As traditional batch processes give way to more efficient, scalable, and environmentally sustainable methods, the pharmaceutical industry stands at the cusp of an era defined by innovation and precision. Despite the numerous advantages—such as improved process control, reduced variability, and higher throughput—modern granulation is not without challenges. High capital investment, regulatory hurdles, material compatibility, and the demand for skilled manpower represent significant barriers to widespread adoption. However, these challenges also provide fertile ground for innovation. Future research and development efforts will likely center on integrating granulation processes with automation, AI, and real-time analytics to enable smart, continuous manufacturing. The use of green technologies, novel binder systems, and flexible modular equipment will further drive efficiency and sustainability. Personalized medicine, micro-granulation, and Nano-formulations will benefit significantly from advancements in granulation science. In conclusion, while the journey toward universal adoption of modern granulation techniques is complex, the long-term benefits—in terms of product quality, regulatory compliance, and patientcentric design—make it a crucial area of focus for pharmaceutical scientists and engineers. By embracing these innovations and addressing associated challenges head-on, the industry can ensure the production of safer, more effective, and economically viable drug products for future generations.

References

[1] Maurya, A., & Kumar, P. (2018). \"A review on pharmaceutical granulation technology.\" Journal of Drug Delivery and Therapeutics, 8(5), 28–33. – Reviews various granulation technologies with focus on current trends. [2] Holm, P., et al. (2009). \"Granule characterization and its influence on tablet compaction.\" Drug Development and Industrial Pharmacy, 35(3), 269–276. – Describes how granule properties affect final product quality. [3] Rowe, R. C., et al. (2006). \"Handbook of pharmaceutical excipients.\" – Provides detailed insight into excipients and their roles in granulation. [4] Thapa, P., et al. (2017). \"Application of twin-screw granulation in pharmaceutical production.\" Pharma Times, 49(6), 43–48. – Demonstrates the application and advantages of twin-screw granulation. [5] Guo, Y., et al. (2013). \"PAT in solid dosage forms: Applications and benefits.\" Journal of Pharmaceutical Innovation, 8(4), 248–256. – Discusses the role of PAT in monitoring granulation processes. [6] Balasubramanian, S., et al. (2014). \"Melt granulation: Techniques and applications.\" Asian Journal of Pharmaceutical Sciences, 9(3), 138–144. – Covers melt granulation’s usefulness for thermolabile drugs. [7] Bakker, M., et al. (2016). \"Spray drying in pharmaceutical granulation: An overview.\" Journal of Controlled Release, 239, 102–114. – Offers an in-depth look at spray drying technology. [8] Ku, M. S. (2011). \"Use of excipients in solid oral dosage forms.\" Pharmaceutical Research, 28(10), 2245–2268. – Emphasizes excipient selection in modern granulation. [9] Gonnissen, Y., et al. (2008). \"Formulation development using QbD principles.\" European Journal of Pharmaceutics and Biopharmaceutics, 68(2), 465–471. – Integrates QbD into granulation development. [10] Patel, D. M., et al. (2010). \"Recent innovations in granulation technology.\" Pharma Review, 8(44), 67–73. – Discusses innovations in equipment and methods. [11] Kleinebudde, P., et al. (2017). \"Granule formation in high shear mixers.\" Powder Technology, 318, 29–34. – Analyzes mixing dynamics in HSG. [12] Kristensen, H. G., & Schaefer, T. (1987). \"Granulation: A review on pharmaceutical wet granulation.\" Drug Development and Industrial Pharmacy, 13(4–5), 803–872. – Offers foundational understanding of wet granulation principles. [13] De Beer, T. R. M., et al. (2011). \"Process analytical technology in the pharmaceutical industry: A review.\" Analytica Chimica Acta, 697(1-2), 1–19. – Reviews PAT tools for granulation. [14] Thoorens, G., et al. (2014). \"Understanding the functionality of starch and its derivatives in tablets.\" International Journal of Pharmaceutics, 469(1), 97–112. – Assesses starch’s role in granulation. [15] Thapa, P., et al. (2018). \"A comparative study of granulation methods for better drug delivery.\" International Journal of Pharmaceutical Investigation, 8(1), 20–26. – Compares traditional and modern granulation techniques. [16] Aulton, M. E., & Taylor, K. M. G. (2018). Aulton\'s Pharmaceutics: The Design and Manufacture of Medicines (5th ed.). Elsevier. [17] Pandey, P., & Venkatesh, D. N. (2021). Advances in pharmaceutical granulation: Current trends and future perspectives. International Journal of Pharmaceutical Sciences and Research, 12(5), 2537–2547. [18] Vervaet, C., & Remon, J. P. (2005). Continuous granulation in the pharmaceutical industry. Chemical Engineering Science, 60(14), 3949–3957. [19] Leane, M., Pitt, K., Reynolds, G., & Tobyn, M. (2015). A proposal for a drug product manufacturing classification system. Pharmaceutical Development and Technology, 20(1), 12–21. [20] ICH. (2009). Q8(R2) Pharmaceutical Development. International Council for Harmonisation. [21] Food and Drug Administration. (2015). Guidance for Industry: Process Validation: General Principles and Practices. U.S. Department of Health and Human Services. [22] Kleinebudde, P. (2004). Roll compaction/dry granulation: Pharmaceutical applications. European Journal of Pharmaceutics and Biopharmaceutics, 58(2), 317–326. [23] Salm, N., Nystrom, C., & Alderborn, G. (2011). The use of melt granulation in pharmaceutical applications. Pharmaceutical Research, 28(8), 2075–2085. [24] Patil, H., Tiwari, R. V., & Repka, M. A. (2016). Hot-melt extrusion: From theory to application in pharmaceutical formulation. AAPS PharmSciTech, 17(1), 20–42. [25] Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (2009). Handbook of Pharmaceutical Excipients (6th ed.). Pharmaceutical Press. [26] Vromans, H., & Lerk, C. F. (2002). Flow properties of granular materials. International Journal of Pharmaceutics, 248(1–2), 123–131. [27] Nastruzzi, C., & Cortesi, R. (2007). Spray drying for pharmaceutical applications. Drug Delivery and Translational Research, 7(3), 123–132. [28] Porter, S. C. (2005). Aqueous film-coating of tablets: An overview. Drug Development and Industrial Pharmacy, 21(9), 947–963. [29] Roberts, R. J., & Rowe, R. C. (1985). The effect of process variables on the properties of spraydried granules. International Journal of Pharmaceutics, 25(2–3), 159–170. [30] Rantanen, J., & Khinast, J. (2015). The future of pharmaceutical manufacturing sciences. Journal of Pharmaceutical Sciences, 104(11), 3612–3638. [31] U.S. Pharmacopeial Convention. (2023). United States Pharmacopeia 47–NF 42. USP. [32] Pein, M., & Kleinebudde, P. (2006). Development and characterization of melt granulated solid dosage forms. European Journal of Pharmaceutics and Biopharmaceutics, 62(2), 196– 204. [33] Ghugare, P. D., & Chaudhari, S. P. (2019). Melt granulation: An emerging technique in pharmaceutical industry. Asian Journal of Pharmaceutical Technology, 9(1), 48–53. [34] Wu, C. Y., & Sun, C. C. (2013). Predictive modeling for powder behavior in drug development. Advanced Drug Delivery Reviews, 64(4), 456–474. [35] Van Snick, B., et al. (2021). Continuous manufacturing of solid dosage forms: Current status and future perspectives. Pharmaceutical Research, 38(3), 441–459.

Copyright

Copyright © 2025 Mr. Guruprasad Nagraj Patil, Prof. Shoaib Pinjari. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.